Neurocutaneous disorders

Dermatologic Clinics

Volumn 20, Issue 3, 2002, Pages 547-560

  Barbagallo, Joseph S ^a   Kolodzieh, Meghan S ^a   Silverberg, Nanette B ^a   Weinberg, Jeffrey M ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; CLASSIFICATION; GENETICS; HUMAN; INCONTINENTIA PIGMENTI; NEUROFIBROMATOSIS; NEVUS; PARAPROTEINEMIA; PATHOLOGY; PHAKOMATOSIS; REVIEW; SKIN DISEASE; SKIN TUMOR; TUBEROUS SCLEROSIS; XERODERMA PIGMENTOSUM; AUTOSOMAL DOMINANT DISORDER; CANCER RISK; MENKES SYNDROME; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SCREENING;

ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; HUMANS; INCONTINENTIA PIGMENTI; NEUROCUTANEOUS SYNDROMES; NEUROFIBROMATOSES; NEVUS; POEMS SYNDROME; SKIN DISEASES; SKIN NEOPLASMS; TUBEROUS SCLEROSIS; XERODERMA PIGMENTOSUM; HUMAN;

EID: 0036323114     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00005-0     Document Type: Review

References (129)

1. Neurofibromatosis: A common neurocutaneous disorder
2. Physical mapping of a translocation breakpoint in neurofibromatosis
3. J. Aberrant regulation of ras proteins in neurofibromatosis type 1 patients
4. Homozygous inactivation of the NF1 gene in bone marrow cells from children with NF1 and malignant myeloid disorders
5. Patemal origin of new mutations in neurofibromatosis
6. Somatic mosaicism in a patient with neurofibromatosis type 1
7. Otologic manifestations of neurofibromatosis
8. Visual function in neurofibromatosis
9. Neurofibromatosis type 1: The cognitive phenotype
10. The diagnostic evaluation and multidisciplinary management of neurofibromatosis types 1 and 2
11. Malignancy in neurofibromatosis
12. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis
13. American Academy of Pediatrics: Health supervision for children with neurofibromatosis
14. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)
15. Central neurofibromatosis
16. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis
17. Neurofibromatosis 2: Clinical characteristics of 63 affected individuals and clinical evidence of heterogeneity
18. A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas
19. Lens opacities in neurofibromatosis 2: Further significant correlations
20. Neuro-fibromatosis 1 and 2: An update
21. Screening for truncated NF1 proteins
22. Molecular genetic screening for children at risk for neurofibromatosis 2
23. Tuberous sclerosis
24. Epidemiology of tuberous sclerosis
25. Tuberous sclerosis
26. Detection of tuberous sclerosis in patients by magnetic resonance imaging
27. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 member for polycystic kidney diseasea contiguous gene syndrome
28. Two loci for tuberous sclerosis
29. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic cases tuberous sclerosis
30. The molecular genetics of tuberous sclerosis
31. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
32. Diagnosis and management of neurocutaneous syndromes
33. Tuberous sclerosis consensus conference: Revised clinical diagnostic criteria
34. Surgical management and seizure outcome in patients with tuberous sclerosis
35. Surgical treatment of intraventricular tumors associated with tuberous sclerosis
36. The value of renal scintigraphy in the conservative management of a patient with tuberous sclerosis
37. Mortality in the Mayo Clinic tuberous sclerosis complex study
38. The management of renal angiomyolipoma
39. Diagnosis of tuberous sclerosis
40. Patching together the genetics of Gorlin syndrome
41. Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome
42. Nevoid basal-cell carcinoma syndrome
43. Cysts of the jaw as part of a hereditary syndrome
44. Metastasizing basal cell carcinoma
45. Metastatic basal cell carcinoma with squamous appearance in the nevoid basal cell carcinoma syndrome
46. Structure and significance of the pits with their tumors in the nevoid basal cell carcinoma syndrome
47. Craniofacial morphology in the nevoid basal cell carcinoma syndrome
48. Nevoid basal cell carcinoma syndrome: Radiographic manifestations including cystlike lesions of the phalanges
49. Microscopically controlled surgery for carcinomas in patients with nevoid basal cell carcinoma syndrome
50. The nevoid basal-cell carcinoma syndrome. Simultaneous extirpation of numerous basal cell carcinomas of the face by curettage and electrodesiccation under general anesthesia
51. Topical 5-fluorouracil and the basal call nevus syndrome
52. Aromatic retinoid in the chemoprevention of the progression of nevoid basal cell carcinoma syndrome
53. Epidermal nevi and the epidermal nevus syndrome
54. Nevus unius lateris
55. Epidermal and other organoid nevi
56. Epidermal nevus syndromes
57. Epidermal nevus syndrome: Report of association with chondroblastoma of bone
58. Epidermal nevus syndrome: Case report and review of clinical manifestations
59. Epidermal nevus syndrome: Report of association with a transitional cell carcinoma of the bladder
60. Linear sebaceous nevus syndrome. A hamartoma variant
61. Nevus sebaceous (Jadassohn) complicated by bilateral salivary gland adenocarcinoma
62. Linear nevus sebaceous: Report of two cases and a review of the literature
63. Epidermal nevus syndrome with development of a mandibular ameloblastoma
64. Genetic and clinical mosaicism in a type of epidermal nevus
65. Xeroderma pigmentosum. Cutaneous ocular and neurologic abnormalities in 830 published cases
66. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm
67. Defective repair replication of DNA in Xeroderma pigmentosum cell strains
68. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after UV radiation
69. Dermabrasion for the treatment of xeroderma pigmentosum
70. Retinoid chemoprevention in the high-risk patient
71. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomized study
72. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease
73. Genetic aspects of ataxia-telangiectasia
74. Ataxia telangiectasia genes and predisposition to leukemia, lymphoma and breast cancer
75. Radiation-induced division delay in synchronized Chinese hamster ovary cells in monolayer culture
76. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells
77. Unusual sensitivity of ataxia-telangiectasia cells to bleomycin
78. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species
79. The ataxiatelangiectasia gene product, a constutively expressed nuclear protein that is not up-regulated following genomic damage
80. Ataxia-telangiectasia: An overview
81. Ataxia-telangiectasia: A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on seven children, an autopsy and a case history
82. Immunoglobulin E deficiency in ataxia-telangiectasia
83. Cutaneous granulomatous lesions in patients with ataxia-telangiectasia
84. A low molecular weight immunoglobulin antigenically related to 19S IgM
85. Autoimmune phenomena in ataxia-telangiectasia
86. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia
87. Breast and other cancers in families with ataxia-telangiectasia
88. Tests appropriate for the prenatal diagnosis of ataxia-telangiectasia
89. Incontinentia pigmenti
90. Incontinentia pigmenti
91. Multiple pathogenic and benign genomic rearrangements occur at 35kb duplication involving NEMO and LAGE2 genes
92. Recent progress in the genetics of incontinentia pigmenti (Bloch-Schulzberg syndrome)
93. Linkage analysis in 16 families with incontinentia pigmenti
94. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2
95. Genetic aspects of Klippel-Trenaunnay syndrome
96. Incontinentia pigmenti. A world statistical analysis
97. Incontinetia pigmenti: A four generation study
98. Incontinentia pigmenti (Bloch-Sulzberger syndrome)
99. Characteristic MR findings in a neonate with incontinentia pigmenti
100. Cerebral infarction in incontinentia pigmenti: The first report of a case evaluated by single photon emission computed tomography
101. Miscellaneous genodermatoses
102. Menkes' disease
103. Incidence of Menkes disease
104. Multipoint linkage analysis in Menkes disease
105. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase
106. Menkes disease
107. Tissue copper concentrations of patients with Menkes' kinky hair disease
108. Menkes' kinky hair syndrome: Ultrastructural cutaneous alterations of the elastic fibers
109. Life span and Menkes kinky hair syndrome: Report of a 13-year course of this disease
110. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease
111. Prenatal and postnatal diagnosis of Menkes disease, an inherited disorder of copper metabolism
112. Pathological findings in three non-Japanese patients with the POEMS syndrome
113. Plasma cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome
114. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome
115. Growth factors in POEMS syndrome: Evidence for a marked increase in circulating vascular endothelial growth factor
116. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome
117. Plasma cell dyscrasia with polyneuritis and dermatoendocrine alterations. Report of a new case outside Japan
118. POEMS syndrome: A study of 25 cases and a review of the literature
119. POEMS syndrome in a patient with diabetic ketoacidosis: Case report and review
120. POEMS syndrome with neuroarthropathy and nodular regenerative hyperplasia of the liver
121. P.O.E.M.S. syndrome with complete recovery after treatment of a solitary plasmocytoma
122. Simultaneous occurrence of Epstein-Barr virus associated Hodgkin's disease and HHV-8 related multicentric Castleman's disease: A fortuitous event?
123. The endocrinopathy of POEMS syndrome
124. Osteosclerotic myeloma and 'POEMS' syndrome
125. Osteosclerotic myeloma and peripheral neuropathy. A case report
126. Severe aggravation of neuropathy in POEMS syndrome after treatment with vincristine
127. All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines